Literature DB >> 10614528

Ras mutations are uncommon in sporadic thyroid cancer in children and young adults.

C Fenton1, J Anderson, Y Lukes, C A Dinauer, R M Tuttle, G L Francis.   

Abstract

Mutations in the ras genes (H-ras, K-ras, and N-ras) occur in 10-15% of all human cancers, and commonly arise from single base substitutions at codons 12, 13, or 61. Although ras mutations have been found in adult thyroid cancers, they were absent from the two studies which examined childhood thyroid cancers. Both studies included only children with radiation induced thyroid cancer, and it remains unclear if ras mutations occur in children without radiation exposure. To answer this question, we examined archival tissue blocks from 31 children with papillary thyroid cancer (PTC) 4 with follicular thyroid cancer (FTC), 2 with medullary thyroid cancer (MTC), and 1 with lymphoma (LYM). Only 1 patient with PTC had previous radiation exposure. Genomic DNA was extracted and used for PCR amplification of the ras genes. The PCR products were analyzed by oligospecific hybridization for mutations at codons 12, 13, and 61. Two of the PTCs (6.5%) contained ras mutations. Both patients had class II disease and no history of previous radiation exposure. One patient subsequently developed bone and lung metastases. The patient with lymphoma also had a ras mutation (N-61), but ras mutations were absent from all FTC and MTC. These results suggest that ras mutations are uncommon in spontaneous childhood thyroid cancer, but occur with a frequency similar to that found in previous reports of adult differentiated thyroid cancers. The number of subjects was too small to determine if ras mutations are more common in patients with aggressive papillary thyroid cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10614528     DOI: 10.1007/BF03343644

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

Review 1.  Thyroid cancer in childhood.

Authors:  J B Gorlin; S E Sallan
Journal:  Endocrinol Metab Clin North Am       Date:  1990-09       Impact factor: 4.741

Review 2.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

3.  Absence of G(s)alpha gene mutations in childhood thyroid tumors after Chernobyl in contrast to sporadic adult thyroid neoplasia.

Authors:  V Waldmann; H M Rabes
Journal:  Cancer Res       Date:  1997-06-15       Impact factor: 12.701

4.  The expression of myc and ras oncogene protein in childhood lymphomas.

Authors:  A Sakalidou; P Kanavaros; M Tzardi; M Kalmanti
Journal:  Anticancer Res       Date:  1996 Jan-Feb       Impact factor: 2.480

5.  Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults.

Authors:  C A Welch Dinauer; R M Tuttle; D K Robie; D R McClellan; R L Svec; C Adair; G L Francis
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

Review 6.  Epidemiology and therapy of thyroid cancer in childhood and adolescence.

Authors:  P Bucsky; T Parlowsky
Journal:  Exp Clin Endocrinol Diabetes       Date:  1997       Impact factor: 2.949

7.  Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

Authors:  F D Gilliland; W C Hunt; D M Morris; C R Key
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

8.  High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.

Authors:  Y F Shi; M J Zou; H Schmidt; F Juhasz; V Stensky; D Robb; N R Farid
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

9.  Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues.

Authors:  G Capella; X Matias-Guiu; X Ampudia; A de Leiva; M Perucho; J Prat
Journal:  Diagn Mol Pathol       Date:  1996-03

10.  The expression of the ras p21 oncoprotein in the bone marrow smears of children with acute leukemia.

Authors:  M Kalmanti; T Kalmantis; M Vassilaki; A Galanopoulos; D Grenzelias; D A Spandidos
Journal:  Anticancer Res       Date:  1992 Nov-Dec       Impact factor: 2.480

View more
  9 in total

Review 1.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.

Authors:  Scott A Rivkees; Ernest L Mazzaferri; Frederik A Verburg; Christoph Reiners; Markus Luster; Christopher K Breuer; Catherine A Dinauer; Robert Udelsman
Journal:  Endocr Rev       Date:  2011-08-31       Impact factor: 19.871

2.  Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.

Authors:  A M Straight; A Patel; C Fenton; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

3.  Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents.

Authors:  A Patel; A M Straight; H Mann; E Duffy; C Fenton; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

Review 4.  Epidemiology and treatment of head and neck malignancies in the AYA generation.

Authors:  Takahiro Asakage
Journal:  Int J Clin Oncol       Date:  2022-01-14       Impact factor: 3.402

5.  Ki-ras mutational analysis in rat follicular-cell proliferative lesions of the thyroid gland induced by radioactive iodine and potassium perchlorate.

Authors:  J M Fernández-Santos; M De-Miguel; R González-Cámpora; M Salguero-Villadiego; J J Cabrera; H Galera-Davidson
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

6.  Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon.

Authors:  A Boichard; L Croux; A Al Ghuzlan; S Broutin; C Dupuy; S Leboulleux; M Schlumberger; J M Bidart; L Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2012-08-03       Impact factor: 5.958

7.  Association of DNMT3B -283 T > C and -579 G > T polymorphisms with decreased cancer risk: evidence from a meta-analysis.

Authors:  Yang Zhang; Haisheng Xu; Yi Shen; Zhimin Gong; Tianlin Xiao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation.

Authors:  Maria Eleni Nikita; Wen Jiang; Shih-Min Cheng; Feras M Hantash; Michael J McPhaul; Robert O Newbury; Susan A Phillips; Richard E Reitz; Frederic M Waldman; Ron S Newfield
Journal:  Thyroid       Date:  2016-01-07       Impact factor: 6.568

Review 9.  Thyroid Cancer in the Pediatric Population.

Authors:  Vera A Paulson; Erin R Rudzinski; Douglas S Hawkins
Journal:  Genes (Basel)       Date:  2019-09-18       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.